PRESS RELEASE published on 12/03/2025 at 15:23, 9 months 14 days ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc The Vanguard Group, Inc. discloses a 5.73% stake in Avadel Pharmaceuticals plc as of 02 December 2025 under Rule 8.3 of the Irish Takeover Panel Act Form 8.3 Irish Takeover Panel IRSH Vanguard Group Avadel Pharmaceuticals Plc
PRESS RELEASE published on 12/03/2025 at 15:22, 9 months 14 days ago Form 8.3 - The Vanguard Group, Inc.: Unite Group plc, The The Vanguard Group, Inc. discloses 4.96% ownership of Unite Group plc, The. Recent securities transactions indicated Vanguard Group Ownership Disclosure Financial Disclosure Securities Transactions Unite Group Plc
BRIEF published on 12/02/2025 at 16:07, 9 months 15 days ago The Vanguard Group Discloses Position in Qualcomm Takeover Code Vanguard Group Stock Transactions Shareholding Disclosure Qualcomm
BRIEF published on 12/02/2025 at 16:06, 9 months 15 days ago Vanguard's Interest in American Axle & Manufacturing Takeover Code Vanguard Group Shareholding Stock Transactions American Axle
BRIEF published on 12/02/2025 at 16:05, 9 months 15 days ago The Vanguard Group Discloses Stake in JTC plc Takeover Code Stock Trading Securities Disclosure Vanguard Group JTC Plc
BRIEF published on 12/02/2025 at 16:04, 9 months 15 days ago The Vanguard Group Discloses Interests in Avadel Pharmaceuticals Form 8.3 Irish Takeover Panel Securities Disclosure Vanguard Group Avadel Pharmaceuticals
BRIEF published on 12/02/2025 at 16:03, 9 months 15 days ago Vanguard Group Discloses Position in Greencore Group Form 8.3 Takeover Code Vanguard Group Shareholding Greencore Group
PRESS RELEASE published on 12/02/2025 at 16:02, 9 months 15 days ago Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated The Vanguard Group, Inc. discloses a 10.79% interest in Qualcomm Incorporated. Additional disclosures include dealings in relevant securities Securities Disclosure Vanguard Group Dealings Qualcomm
BRIEF published on 12/02/2025 at 16:02, 9 months 15 days ago The Vanguard Group Discloses Position in Spire Healthcare Investment Takeover Code Securities Disclosure Vanguard Group Spire Healthcare
PRESS RELEASE published on 12/02/2025 at 16:01, 9 months 15 days ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc. The Vanguard Group, Inc. discloses a 7.50% ownership stake in American Axle & Manufacturing Holdings, Inc. with 8,897,240 relevant securities held on 01 Dec 2025 The Vanguard Group, Inc. Relevant Securities Disclosure Ownership Stake American Axle & Manufacturing Holdings, Inc.
Published on 09/18/2026 at 06:30, 5 hours 56 minutes ago GREE Chairperson Dong Mingzhu Honored by UNEP Cool Coalition for Leadership in Sustainable Cooling
Published on 09/18/2026 at 00:55, 11 hours 31 minutes ago Tectonic Metals Announces Results of the 2026 Annual General Meeting
Published on 09/18/2026 at 00:25, 12 hours 1 minute ago CoTec Holdings Corp. Announces Initial Closing of Private Placement of Unsecured Convertible Debentures
Published on 09/17/2026 at 22:15, 14 hours 11 minutes ago Rocky Shore Gold Announces Non-Brokered Private Placement
Published on 09/18/2026 at 12:00, 26 minutes ago BIRKENSTOCK OPENS A NEW STORE IN THE HEART OF BERLIN
Published on 09/18/2026 at 12:00, 26 minutes ago Warren Wise scans Siemens Healthineers: Sharp images for doctors, blurry ones for investors
Published on 09/18/2026 at 11:55, 31 minutes ago Xryma Plc Reports Steady H1 2026 Results While Positioning the Group for Its Next Phase of Growth
Published on 09/18/2026 at 11:50, 36 minutes ago German Companies Advance Investment Projects Worth More Than €600 Million in Latvia
Published on 09/18/2026 at 11:35, 51 minutes ago Huawei Unveils Upgraded Stellar AI Network to Power the Agentic World with Secure, Intelligent Connectivity
Published on 09/17/2026 at 17:40, 18 hours 46 minutes ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
Published on 09/16/2026 at 17:45, 1 day 18 hours ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 2 days 5 hours ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
